Xcout Intel
Tortugas Neuroscience
Tortugas Neuroscience is a drug discovery and biopharmaceutical company headquartered in Framingham, Massachusetts. The company focuses on advancing innovative neuroscience therapeutics.
Subscribe to see Tortugas Neuroscience’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tortugas Neuroscience at a glance
Tortugas Neuroscience is a drug discovery company headquartered in United States. Its most recent funding round, Seed and Series A, raised $106M in April 2026. Xcout tracks 1 named person at Tortugas Neuroscience, including Jeff Jonas (CEO).
Tortugas Neuroscience leadership
- Jeff JonasCEO
Tortugas Neuroscience funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed and Series A | $106M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Tortugas Neuroscience competitors
A few of Tortugas Neuroscience's closest competitors — see the full list of competitors and alternatives →
Neurasic Therapeutics is a Montreal-based drug discovery company founded in 2020 and based on research from McGill University's Montreal Neurological Institute. The company develops therapeutic solutions and medicinal drugs aimed at treating neurological disorders, with a primary focus on advancing opiate-sparing, pain-relieving treatments such as substituted thiophene for neuropathic and inflammatory pain.
Vima Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm pioneers treatments for dystonia and related movement disorders, focusing on novel oral therapies. It develops specialized therapeutics designed to help patients regain mobility and freedom of movement.
FundaMental Pharma is a biopharmaceutical spin-off established from Heidelberg University and headquartered in Heidelberg, Germany. Its research focuses on developing novel therapeutic approaches and treatments for neurological disorders.
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Goldenrod Therapeutics, Inc. is a biotechnology innovator based in Houston, Texas, developing treatments for brain inflammation and PDE4B inhibitors for neurological conditions and substance use disorder.
Get Tortugas Neuroscience's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Tortugas Neuroscience in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access